Skip to main content
. 2017 Jun 6;2017(6):CD012143. doi: 10.1002/14651858.CD012143.pub2
Methods For characteristics see Foster 2015a2
Participants
Interventions
Outcomes
Notes
Risk of bias
Bias Authors' judgement Support for judgement
Random sequence generation (selection bias) Unclear risk Not described
Allocation concealment (selection bias) Low risk An Interactive Web Response System was used
Blinding of participants and personnel (performance bias) All outcomes High risk Described as open‐label
Blinding of outcome assessment (detection bias) All outcomes High risk Described as open‐label
Incomplete outcome data (attrition bias) All outcomes Low risk Only 5 participants dropped out
Selective reporting (reporting bias) High risk SVR 24 was not reported as described in the prepublished protocol (NCT02220998 and supplementary material at NEJM.org)
Vested‐interest bias High risk The trial was funded by a company that might have an interest in a given result (Gilead Sciences)
Other bias Low risk The trial appeared to be free of other components that could put it at risk of bias